Synthesis, characterization and interaction studies of copper based drug with Human Serum Albumin (HSA): Spectroscopic and molecular docking investigations

Journal of Photochemistry and Photobiology B: Biology

Volumn 114, Issue , 2012, Pages 132-139

  Tabassum, Sartaj ^a   Al Asbahy, Waddhaah M ^a   Afzal, Mohd ^a   Arjmand, Farukh ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Fluorescence quenching; Fourier transformation infrared spectra (FT IR); Human Serum Albumin (HSA); Molecular modeling; Sulfa drugs

Indexed keywords

BUFFER; COPPER COMPLEX; HUMAN SERUM ALBUMIN; SALAZOSULFAPYRIDINE;

ARTICLE; BINDING SITE; CIRCULAR DICHROISM; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUORESCENCE SPECTROSCOPY; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; GEOMETRY; HUMAN; HYDROGEN BOND; HYDROPHOBICITY; INFRARED SPECTROSCOPY; MOLECULAR DOCKING; PRIORITY JOURNAL; TEMPERATURE; THERMODYNAMICS; TITRIMETRY; ULTRAVIOLET SPECTROSCOPY;

BINDING SITES; COMPUTER SIMULATION; COORDINATION COMPLEXES; COPPER; ENERGY TRANSFER; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SERUM ALBUMIN; THERMODYNAMICS;

EID: 84864279244     PISSN: 10111344     EISSN: 18732682     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2012.05.021     Document Type: Article

References (51)

1. 2+ on the interaction between an antitumor drug-mitoxantrone and human serum albumin J. Mol. Struct. 892 2008 20 24
2. F. Faridbod, M.R. Ganjali, B. Larijani, S. Riahi, A.A. Saboury, M. Hosseini, P. Norouzi, and C. Pillip Interaction study of pioglitazone with albumin by fluorescence spectroscopy and molecular docking Spectrochim. Acta Part A 78 2011 96 101
3. N. Shahabadi, and M. Maghsudi Binding studies of a new copper (II) complex containing mixed aliphatic and aromatic dinitrogen ligands with bovine serum albumin using different instrumental methods J. Mol. Struct. 929 2009 193 199
4. T. Peters All About Albumin 1996 Academic Press San Diego, CA
5. W.H. Ang, E. Daldini, L. Juillerat-Jeanneret, and P.J. Dyson Strategy to tether organometallic ruthenium-arene anticancer compounds to recombinant human serum albumin Inorg. Chem. 46 2007 9048 9050
6. V.T.G. Chuang, U. Kragh-Hansen, and M. Otagiri Pharmaceutical strategies utilizing recombinant human serum albumin Pharm. Res. 19 2002 569 577
7. K. Yamasaki, T. Maruyama, U. Kragh-Hansen, and M. Otagiri Characterization of site I on human serum albumin: concept about the structure of a drug binding site Biochim. Biophys. Acta 1295 1996 147 157
8. I. Sjoholm, B. Ekman, A. Kober, I. Ljungstedt-Pahlman, B. Seiving, and T. Sjodin Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles Mol. Pharmacol. 16 1979 767 777
9. F. Chiappori, P. D'Ursi, I. Merelli, L. Milanesi, and E. Rovida In silico saturation mutagenesis and docking screening for the analysis of protein-ligand interaction: the endothelial protein C receptor case study BMC Bioinf. 10 2009 S3
10. J.C. Mai, Z. Mi, S.-H. Kim, B. Ng, and P.D. Robbins A proapoptotic peptide for the treatment of solid tumor Cancer Res. 61 2001 7709 7712
11. R.A. Cruciani, J.L. Barker, M. Zasloff, H.C. Chen, and O. Colamonici Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation Proc. Natl. Acad. Sci. USA 88 1991 3792 3796
12. S.A. Johnstone, K. Gelmon, L.D. Mayer, R.E. Hancock, and M.B. Bally In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines Anticancer Drug Des. 15 2000 151 160
13. F.J. Sharom, G. DiDiodota, X. Yu, and K.J.D. Ashbourne Interaction of the p-glycoprotein multidrug transporter with peptides and ionophores J. Biol. Chem. 270 1995 10334 10341
14. S.B. Hanauer, W.J. Sandborn, A. Kornbluth, S. Katz, M. Safdi, S. Woogen, G. Regalli, C. Yeh, N. Smith-Hall, and F. Ajayi Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial Am. J. Gastroenterol. 100 2005 2478 2485
15. C.M. Sharaby Studies of some new cyclodiphosphazane complexes of Fe(III), Fe(II), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) Synth. React. Inorg. Met. Org. Chem. 35 2005 133 142
16. R.B.P. Elmes, M. Erby, S.M. Cloonan, S.J. Quinn, D.C. Williams, and T. Gunnlaugsson Quaternarized pdppz: synthesis, DNA-binding and biological studies of a novel dppz derivative that causes cellular death upon light irradiation Chem. Commun. 47 2011 686 688
17. A. Massey, Y.-Z. Xu, and P. Karran Photoactivation of DNA thiobases as a potential novel therapeutic option Curr. Biol. 11 2001 1142 1146
18. G. Tamasi, F. Serinelli, M. Consumi, A. Magnani, M. Casolaro, and R. Cini Release studies from smart hydrogels as carriers for piroxicam and copper(II)-oxicam complexes as anti-inflammatory and anti-cancer drugs. X-ray structures of new copper(II)-piroxicam and -isoxicam complex molecules J. Inorg. Biochem. 102 2008 1862 1873
19. B.N. Ames, M.K. Shigenaga, and T.M. Hagen Oxidants, antioxidants, and the degenerative diseases of aging Proc. Natl. Acad. Sci. USA 90 1993 7915 7922
20. C.N. Pace, F. Vajdos, L. Fee, G. Grimsley, and T. Gray How to measure and predict the molar absorption coefficient of a protein Prot. Sci. 4 1995 2411 2423
21. J.R. Lakowicz Principles of Fluorescence Spectroscopy second ed. 1999 Plenum Press New York pp. 237-265
22. A. Sharma, and S.G. Schulman Introduction to Fluorescence Spectroscopy 1999 John Wiley & Sons, Inc. New York pp. 58-59
23. T. Förster, and O. Sinanoglu Modern Quantum Chemistry vol. 3 1996 Academic Press New York pp. 93-138
24. L. Cyril, J.K. Earl, and W.M. Sperry Biochemists' Handbook 1961 E. & F.N. Spon London p. 84
25. Z.X. Lu, T. Cui, and Q.L. Shi Applications of circular dichroism and optical rotatory dispersion in molecular biology first ed. 1987 Science Press pp. 79-82
26. D. Mustard, and D.W. Ritchie Docking essential dynamics eigenstructures Prot.: Struct. Funct. Bioinf. 60 2005 269 274
27. J. Dehand, J. Jordanov, F. Keck, A. Mosset, J.J. Bonnet, and J. Galy Synthesis, crystal structure, and electronic properties of (L- methionylglycinato)copper(II) Inorg. Chem. 18 1979 1543 1549
28. H. Sigel, and R.B. Martin Coordinating properties of the amide bond. Stability and structure of metal ion complexes of peptides and related ligands Chem. Rev. 82 1982 385 426
29. M.S. Refat, and S.F. Mohamed Spectroscopic, thermal and antitumor investigations of sulfasalazine drug in situ complexation with alkaline earth metal ions Spectrochim. A 82 2011 108 117
30. I.A. Koval, M. Sgobba, M. Huisman, M. Lüken, E. Saint-Aman, P. Gamez, B. Krebs, and J. Reedijk A remarkable anion effect on the crystal packing of two analogous copper complexes from a thiophene-containing phenol-based ligand Inorg. Chim. Acta. 359 2006 4071 4078
31. E. Manessi-Zoupa, S.P. Perlepes, V. Hondrellis, and J.M. Tsangaris Transition metal complexes of N-(2-benzamide)pyridine-2′-carboxamide, a potentially tridentate ligand containing one secondary and one primary amide group: preparation and characterization in the solid state J. Inorg. Biochem. 55 1994 217 233
32. J. Moncol, M. Mudra, P. Lönnecke, M. Hewitt, M. Valko, H. Morris, J. Svorec, M. Melnik, M. Mazur, and M. Koman Crystal structures and spectroscopic behavior of monomeric, dimeric and polymeric copper(II) chloroacetate adducts with isonicotinamide, N-methylnicotinamide and N, N-diethylnicotinamide Inorg. Chim. Acta 360 2007 3213 3225
33. B.J. Hathaway, and D.E. Billing The electronic properties and stereochemistry of mono-nuclear complexes of the copper(II) ion Coord. Chem. Rev. 5 1970 143 207
34. D. Kivelson, and R. Neiman ESR studies on the bonding in copper complexes J. Chem. Phys. 35 1961 149 155
35. D.C. Carter, and J.X. Ho Structure of serum albumin Adv. Prot. Chem. 45 1994 153 203
36. A. Sułkowska, B. Bojko, J. Rownicka, and W.W. Sułkowski Paracetamol and cytarabine binding competition in high affinity binding sites of transporting protein J. Mol. Struct. 792-793 2006 249 256
37. L. Trynda-Lemiesz, B.K. Keppler, and H. Koztowski Studies on the interactions between human serum albumin and imidazolium [trans-tetrachlorobis (imidazol) ruthenate (III)] J. Inorg. Biochem. 73 1999 123 128
38. J.R. Lakowicz Quenching of fluorescence by oxygen. Probe for structural fluctuations in macromolecules Biochemistry 12 1973 4161 4170
39. D. Silva, C.M. Cortez, and J.C. Bastos Methyl parathion interaction with human and bovine serum albumin Toxicol. Lett. 147 2004 53 61
40. M.X. Xie, M. Long, Y. Liu, C. Qin, and Y.D. Wang Characterization of the interaction between human serum albumin and morin Biochim. Biophys. Acta 1760 2006 1184 1191
41. M.M. Yang, Q. Xiao, and X.L. Xi Study of the interaction of cephalosporin class medicine with albumin by fluorescence enhancement and fluorescence quenching theories Chin. J. Chem. 24 2006 642 648
42. Y.Z. Zhang, B. Zhou, Y.X. Liu, C.X. Zhou, X.L. Ding, and Y. Liu Fluorescence study on the interaction of bovine serum albumin with P-aminoazobenzene J. Fluor. 18 2008 109 118
43. P.D. Ross, and S. Subramanian Thermodynamics of protein association reactions: forces contributing to stability Biochemistry 20 1981 3096 3102
44. B. Valeur, and J.C. Brochon New Trends in Fluorescence Spectroscopy sixth ed. 1999 Springer Press Berlin pp. 25
45. P.B. Kandagal, S. Ashoka, J. Seetharamappa, S.M.T. Shaikh, Y. Jadegoud, and O.B. Ijare Study of the interaction of an anticancer drug with human and bovine serum albumin: spectroscopic approach J. Pharm. Biomed. 41 2006 pp. 393-399
46. B. Ahmad, S. Parveen, and R.H. Khan Effect of albumin conformation on the binding of ciprofloxacin to human serum albumin: a novel approach directly assigning binding site Biomacromolecules 7 2006 1350 1356
47. F. Cui, J. Fan, J. Li, and Z. Hu Interactions between 1-benzoyl-4-p-chlorophenylb thiosemicarbazide and serum albumin: investigation by fluorescence spectroscopy Bioorg. Med. Chem. 12 2004 151 157
48. W.K. Surewicz, H.H. Mantsch, and D. Chapman Determination of protein secondary structure by Fourier transform infrared spectroscopy: a critical assessment Biochemistry 32 1993 389 394
49. Y. Li, W.Y. He, Y. Dong, F. Sheng, and Z. Hu Human serum albumin interaction with formononetin studied using fluorescence anisotropy, FT-IR spectroscopy, and molecular modeling methods Bioorg. Med. Chem. 14 2006 1431 1436
50. D.C. Carter, X.M. He, S.H. Munson, P.D. Twigg, K.M. Gernert, M.B. Broom, and T.Y. Miller Three-dimensional structure of human serum albumin Science 244 1989 1195 1198
51. J. Tang, F. Luan, and X. Chen Binding analysis of glycyrrhetinic acid to human serum albumin: fluorescence spectroscopy, FTIR, and molecular modeling Bioorg. Med. Chem. 14 2006 3210 3217